In ccRCC, we demonstrated that TRIM8 is a direct p53 target gene that - through a feedback loop mechanism - appears to be a pivotal component in controlling the molecular switch that directs p53 toward transcriptional activation of cell cycle arrest genes, such as p21 and GADD45 [2]. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.